awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q39436924-1013C8C0-EE99-43E4-9F6B-2DCD77FDA320
Q39436924-1013C8C0-EE99-43E4-9F6B-2DCD77FDA320
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39436924-1013C8C0-EE99-43E4-9F6B-2DCD77FDA320
Clinical outcomes in recurrent glioblastoma with bevacizumab therapy: An analysis of the literature.
P2860
Q39436924-1013C8C0-EE99-43E4-9F6B-2DCD77FDA320
BestRank
Statement
http://www.wikidata.org/entity/statement/Q39436924-1013C8C0-EE99-43E4-9F6B-2DCD77FDA320
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
dd29cedf7b63784890524d3c5444552879c42289
P2860
A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas.